AllSides Balanced Search reveals information and ideas from all sides of the political spectrum so you can get the full picture.
Oct 23 2020
The number of new daily COVID-19 coronavirus cases is rising in the United States, with some states and regions, such as the Midwest and parts of the West, reportedly seeing significant surges. Multiple reports said there were over 77,000 new virus cases recorded in the U.S. on Thursday. In recent months, scientists and health experts including Dr. Anthony Fauci have warned that surges mayAssociated Press Newsmax (News) Vice
Sep 22 2020
The official death toll from the COVID-19 coronavirus pandemic reportedly surpassed 200,000 on Tuesday.
Overall, the news attracted more prominent attention from left- and center-rated outlets, some of which framed the mark as a sign of the country's purported failure to control the virus. Some coverage from right-rated sources placed more focus on vaccine development progress andAxios Washington Examiner Mother Jones
Jun 25 2020
On Wednesday, the COVID Tracking Project reported that the U.S. set a daily record of 36,880 new coronavirus cases.
The surge in states such as Arizona, Florida and Texas cannot be explained by increased testing alone as the percentage of people testing positive for the virus has also surged.The Hill Washington Post Fox News (Online News)
Oct 06 2020
President Trump continues treatment for the coronavirus after returning to the White House Monday evening.
Trump tweeted in part, "Feeling really good! Don’t be afraid of Covid. Don’t let it dominate your life" Monday afternoon before leaving the hospital. Critics say that Trump's comments minimize the pandemic as a number of White House officials have tested positive for theNPR (Online News) Washington Post Newsmax (News)
Jul 27 2020
In partnership with the National Institutes of Health, biotechnology company Moderna plans to enroll roughly 30,000 subjects in Phase 3 of its COVID-19 coronavirus vaccine trial. The Biomedical Advanced Research and Development Authority have awarded Moderna another $472 million to fill the gap in needed funds. This brings the company's U.S.-based financial backing to roughly $955 million.The Boston Globe CNET Newsmax (News)
Sep 29 2020
Over 1 million people have died from COVID-19 as of Tuesday, with worldwide cases topping 33.4 million. One fifth of the deaths, over 200,000, were in the United States. COVID-19 has also killed 142,000 in Brazil, 96,000 in India, and 76,000 in Mexico. According to Reuters, the virus kills 5,400 people per day, and 226 people per hour. Furthermore, the rise in deaths has accelerated, doublingCNN (Online News) Associated Press Fox News (Online News)
Sep 09 2020
President Donald Trump told journalist Bob Woodward in February that he intentionally downplayed the coronavirus threat to the Unites States before issuing the government’s initial social distancing guidelines in March. Trump made these comments on-the-record; the interviews will be used in Woodward’s upcoming book on Trump’s presidency, “Rage." CNN obtained an advance copy of “Rage,” as wellThe Daily Wire Reuters CNN (Online News)
Jul 20 2020
According to newly released data, Oxford University's trials on the COVID-19 coronavirus vaccine have produced strong immune responses from subjects. This was the first trial conducted on humans; Oxford is working in tandem with pharmaceutical company AstraZeneca.
Coverage on the matter was generally uniform, irrespective of political leanings. Some voices, including those of worldNational Review HuffPost Reuters
Aug 21 2020
The state of COVID-19 coronavirus testing in the U.S. has drawn additional attention and scrutiny as schools move to reopen safely. Some public health officials are calling for widespread testing before schools resume in-person classes; some federal officials are more in favor of less frequent testing more focused on people with symptoms or relationships with affected individuals.
SomeNational Review CBS News (Online) Wall Street Journal (News)
May 18 2020
Moderna Inc., a biotech company based in Massachusetts, is reporting positive interim data in the first phase of a COVID-19 coronavirus vaccine trial, as immune responses are similar to that in people who had recovered from the disease.
The company is about to begin a phase two trial and hopes to start a phase three trial in July.Newsmax (News) The Hill Washington Post